Form 8-K - Current report:
SEC Accession No. 0001193125-24-223743
Filing Date
2024-09-23
Accepted
2024-09-23 16:44:53
Documents
17
Period of Report
2024-09-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837908d8k.htm   iXBRL 8-K 28196
2 EX-99.1 d837908dex991.htm EX-99.1 11225
7 GRAPHIC g837908dsp005.jpg GRAPHIC 13186
8 GRAPHIC g837908dsp006.jpg GRAPHIC 9769
  Complete submission text file 0001193125-24-223743.txt   235964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240923.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240923_def.xml EX-101.DEF 13866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240923_lab.xml EX-101.LAB 22897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240923_pre.xml EX-101.PRE 14704
19 EXTRACTED XBRL INSTANCE DOCUMENT d837908d8k_htm.xml XML 5886
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241316684
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)